SH3 domains with high affinity and engineered ligand specificities targeted to HIV-1 Nef
- 12 November 1999
- journal article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 293 (5) , 1097-1106
- https://doi.org/10.1006/jmbi.1999.3225
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Novel Peptides Selected to Bind Vascular Endothelial Growth Factor Target the Receptor-Binding SiteBiochemistry, 1998
- RT Loop Flexibility Enhances the Specificity of Src Family SH3 Domains for HIV-1 Nef,Biochemistry, 1998
- Antibody engineeringCurrent Opinion in Structural Biology, 1998
- Selection of Heregulin Variants Having Higher Affinity for the ErbB3 Receptor by Monovalent Phage DisplayPublished by Elsevier ,1998
- Structural Plasticity in a Remodeled Protein-Protein InterfaceScience, 1997
- SH3 domains and drug design: Ligands, structure, and biological functionBiopolymers, 1997
- Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands.Proceedings of the National Academy of Sciences, 1995
- Modular binding domains in signal transduction proteinsCell, 1995
- Two Binding Orientations for Peptides to the Src SH3 Domain: Development of a General Model for SH3-Ligand InteractionsScience, 1994
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973